Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis

by Caroline S. Foo, Andréanne Lupien, Maryline Kienle, Anthony Vocat, Andrej Benjak, Raphael Sommer, Dirk A. Lamprecht, Adrie J. C. Steyn, Kevin Pethe, Jérémie Piton, Karl-Heinz Altmann, Stewart T. Cole
Published 2018-10-01

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.

by Andréanne Lupien, Caroline Shi-Yan Foo, Svetlana Savina, Anthony Vocat, Jérémie Piton, Natalia Monakhova, Andrej Benjak, Dirk A Lamprecht, Adrie J C Steyn, Kevin Pethe, Vadim A Makarov, Stewart T Cole
Published 2020-01-01

Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and f...

by Dany Spaggiari, Vincent Desfontaine, Sandra Cruchon, Sylvie Guinchard, Anthony Vocat, Emilyne Blattes, Jeff Pitteloud, Lorenzo Ciullini, Carine Bardinet, Anton Ivanyuk, Vadim Makarov, Olga Ryabova, Thierry Buclin, Stewart T Cole, Laurent A Decosterd
Published 2019-01-01

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

by Vadim Makarov, Benoit Lechartier, Ming Zhang, João Neres, Astrid M van derSar, Susanne A Raadsen, Ruben C Hartkoorn, Olga B Ryabova, Anthony Vocat, Laurent A Decosterd, Nicolas Widmer, Thierry Buclin, Wilbert Bitter, Koen Andries, Florence Pojer, Paul J Dyson, Stewart T Cole
Published 2014-03-01